TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
MRNA

Moderna Inc

Healthcare · Biotechnology

182.10$ -0.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

Moderna Inc (MRNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 145 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MRNA
Line item Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
108 36 36 42 92 29 29 42 35 16 13 17 14 8.4 66 158 571 1,743 4,215 4,829 6,949 5,940 4,566 3,220 5,149 1,838 344 1,831 2,813 167 221 1,855 956 107 142 1,016 678 389 145 2,228
317 100 100 5.1 5.9 90 104 6.5 7.4 7.3 7.5 7.3 8.9 7.4 7.6 8.5 16 193 750 722 952 1,017 1,381 1,100 1,918 792 731 2,241 929 96 115 514 739 90 119 1,008 452 955 93 2,508
-166 -64 -64 37 86 -61 -76 35 28 8.7 5.6 9.7 5.1 0.9 59 149 555 1,550 3,465 4,107 5,997 4,923 3,185 2,120 3,231 1,046 -387 -410 1,884 71 106 1,341 217 17 23 8.0 226 -566 52 -280
275 100 100 94 118 90 104 109 150 131 128 120 118 115 152 344 759 401 421 521 648 554 710 820 1,211 1,131 1,148 1,160 1,406 1,027 1,221 1,137 1,122 856 700 801 775 649 651 2,876
57 16 16 17 16 16 21 19 38 27 29 28 26 24 37 49 79 77 121 168 201 268 211 278 254 305 332 442 266 274 268 281 351 212 230 268 308 173 216 965
332 16 16 295 128 16 21 121 181 27 149 141 136 132 181 385 830 284 403 549 587 696 738 954 1,651 1,412 1,480 1,602 1,878 1,337 1,469 1,411 1,463 1,067 930 268 1,083 822 867 3,040
-224 -80 -80 -68 -42 -77 -97 -86 -153 -142 -144 -131 -131 -131 -122 -235 -275 1,266 3,062 3,558 5,410 4,227 2,447 1,166 1,580 -366 -1,867 -2,012 6.0 -1,266 -1,363 -70 -1,246 -1,050 -907 -260 -857 -1,388 -815 -3,320
0.3 0.0 0.0 0.3 0.5 0.0 0.0 1.5 1.5 1.5 1.8 1.7 2.0 1.7 1.9 2.8 3.5 3.0 5.0 4.0 6.0 6.0 5.0 8.0 10 9.0 13 10 6.0 6.0 6.0 6.0 6.0 1.0 1.0 0.0 8.0 17 17 42
-215 -77 -77 -65 -38 -72 -90 -80 -141 -133 -135 -123 -123 -124 -117 -233 -271 1,260 3,063 3,552 5,410 4,229 2,474 1,217 1,655 -305 -1,749 -1,958 70 -1,165 -1,279 21 -1,184 -964 -818 -187 -799 -1,334 -767 -3,087
1.0 0.0 0.0 0.0 -0.2 -0.2 0.2 1.2 0.2 0.0 -0.3 -0.2 -0.2 0.1 0.1 0.9 1.5 39 283 219 542 572 277 174 190 -384 -369 1,672 -147 10 – 8.0 -64 7.0 7.0 13 27 9.0 15 64
-216 -80 -80 -68 -38 -72 -91 -80 -141 -133 -135 -123 -123 -124 -117 -234 -272 1,221 2,780 3,333 4,868 3,657 2,197 1,043 1,465 79 -1,380 -3,630 217 -1,175 -1,279 13 -1,120 -971 -825 -200 -826 -1,343 -782 -3,151
– -75 -75 -63 -36 -67 -85 -74 -132 -124 -126 -115 -113 -115 -107 -221 -260 1,278 3,137 3,626 5,488 4,306 2,555 1,338 1,745 -218 -1,646 -1,699 278 -1,123 -1,232 79 -1,118 -924 -760 -135 -732 -1,258 -704 -2,829

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?